BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
2
Emily Crowley, Federica Di Nicolantonio, Fotios Loupakis, Alberto Bardelli. Liquid biopsy: monitoring cancer-genetics in the bloodNature Reviews Clinical Oncology 2013; 10(8): 472 doi: 10.1038/nrclinonc.2013.110
3
Shu-Qiang Yue, Yan-Ling Yang, Ke-Feng Dou, Kai-Zong Li. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasisWorld Journal of Gastroenterology 2003; 9(12): 2863-2865 doi: 10.3748/wjg.v9.i12.2863
4
Huai Wang, Peng Liao, Shelya X Zeng, Hua Lu. It takes a team: a gain-of-function story of p53-R249SJournal of Molecular Cell Biology 2019; 11(4): 277 doi: 10.1093/jmcb/mjy086
5
Filiz Türe Özdemir, Arzu Tiftikci, Seda Sancak, Fatih Eren, Veysel Tahan, Hakan Akın, Feyza Gündüz, Ala Eldeen Kedrah, Yücel Üstündağ, Erol Avşar, Nurdan Tözün, Osman Özdoğan. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in TurkeyJournal of Gastrointestinal Cancer 2010; 41(3): 185 doi: 10.1007/s12029-010-9140-5
6
Peng Lee, Shilpa Jain, Matthew R. Pincus, Ruliang Xu. Henry's Clinical Diagnosis and Management by Laboratory Methods2011; : 1441 doi: 10.1016/B978-1-4377-0974-2.00076-2
7
S. Anitha, D. Raghunadharao, F. Waliyar, H. Sudini, M. Parveen, Ratna Rao, P. Lava Kumar. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, IndiaMutation Research/Genetic Toxicology and Environmental Mutagenesis 2014; 766: 23 doi: 10.1016/j.mrgentox.2013.12.011
8
Vincent L. Chen, Neehar D. Parikh. Liquid Biopsy for Hepatocellular CarcinomaCurrent Hepatology Reports 2019; 18(4): 390 doi: 10.1007/s11901-019-00491-z
9
Ying-Hsiu Su, Selena Y Lin, Wei Song, Surbhi Jain. DNA markers in molecular diagnostics for hepatocellular carcinomaExpert Review of Molecular Diagnostics 2014; 14(7): 803 doi: 10.1586/14737159.2014.946908
10
GERALD C KIMBI, MICHAEL C KEW, MIMI C YU, KAZUKO ARAKAWA, JOHN HODKINSON. 249serp53 mutation in the serum of black southern African patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2005; 20(8): 1185 doi: 10.1111/j.1440-1746.2005.03951.x
11
Paul W. Ewald, Holly A. Swain Ewald. Infection, mutation, and cancer evolutionJournal of Molecular Medicine 2012; 90(5): 535 doi: 10.1007/s00109-012-0891-2
12
Jian Zhou, Ao Huang, Xin-Rong Yang. Liquid Biopsy and its Potential for Management of Hepatocellular CarcinomaJournal of Gastrointestinal Cancer 2016; 47(2): 157 doi: 10.1007/s12029-016-9801-0
13
Michael Torbenson, MD, Rajesh Kannangai, MD, Susan Abraham, MD, Fikret Sahin, MD, PhD, Michael Choti, MD, Jianzhou Wand, PhD, MD. Concurrent Evaluation of p53, b-catenin, and a-Fetoprotein Expression in Human Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2004; 122(3): 377 doi: 10.1309/YH0H-3FKY-M4RM-U1JF
14
Fernanda Magri de Carvalho, Thiago de Almeida Pereira, Patrícia Lofego Gonçalves, Robson Dettmann Jarske, Fausto Edmundo Lima Pereira, Iuri Drumond Louro. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, BrazilMolecular Biology Reports 2013; 40(8): 4883 doi: 10.1007/s11033-013-2587-2
15
Xiao-mo Wu, Jing-geng Fu, Wang-zhong Ge, Jiang-yan Zhu, Jun-yong Wang, Wei Zhang, Wei Qian, Ke-ke Huo. Screen p53 mutations in hepatocellular carcinoma by FASAY: A novel splicing mutationJournal of Zhejiang University SCIENCE B 2007; 8(2): 81 doi: 10.1631/jzus.2007.B0081
16
Xinghua Huang, Guoqing Ji, Yanhua Wu, Bo Wan, Long Yu. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasisJournal of Cancer Research and Clinical Oncology 2008; 134(6): 705 doi: 10.1007/s00432-007-0342-6
17
Yan Liu, Chung-Chou H. Chang, Gary M. Marsh, Felicia Wu. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysisEuropean Journal of Cancer 2012; 48(14): 2125 doi: 10.1016/j.ejca.2012.02.009
18
M. Fleischhacker, B. Schmidt. Circulating nucleic acids (CNAs) and cancer—A surveyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2007; 1775(1): 181 doi: 10.1016/j.bbcan.2006.10.001
19
Klaus Jung, Michael Fleischhacker, Anja Rabien. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureClinica Chimica Acta 2010; 411(21-22): 1611 doi: 10.1016/j.cca.2010.07.032
20
Y.M. Dennis Lo, Rossa W.K. Chiu. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics2012; : 1397 doi: 10.1016/B978-1-4160-6164-9.00045-7
21
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary MalignanciesFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
22
Sherif A. El-Kafrawy, Mohamed Abdel-Hamid, Mai El-Daly, Ola Nada, Alaa Ismail, Sameera Ezzat, Soheir Abdel-Latif, Amany Abdel-Hamid, Peter G. Shields, Christopher Loffredo. p53 Mutations in hepatocellular carcinoma patients in EgyptInternational Journal of Hygiene and Environmental Health 2005; 208(4): 263 doi: 10.1016/j.ijheh.2005.02.002
23
Rufina Igetei, Jesse A. Otegbayo, Dennis A. Ndububa, Olufunmilayo A. Lesi, Chiaka I. Anumudu, Pierre Hainaut, Emmanuelle Gormally. Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNAAnnals of Hepatology 2008; 7(4): 339 doi: 10.1016/S1665-2681(19)31834-4
24
Gabriel D. Dakubo. Cancer Biomarkers in Body Fluids2017; : 247 doi: 10.1007/978-3-319-48360-3_8
25
S. Saleem, Z. A. Abbasi, A. Hameed, N. R. Qureshi, M. A. Khan, A. Azhar. Novel p53 codon 240 Ser > Thr coding region mutation in the patients of oral squamous cell carcinoma (OSCC)Tumor Biology 2014; 35(8): 7945 doi: 10.1007/s13277-014-2062-2
26
HORST H. SCHLECHTE, CORNELIA STELZER, SABINE WEICKMANN, MICHAEL FLEISCHHACKER, GUNTRAM SCHULZE. TP53Gene in Blood Plasma DNA of Tumor PatientsAnnals of the New York Academy of Sciences 2004; 1022(1): 61 doi: 10.1196/annals.1318.011
27
V. B. Weeda, D. C. Aronson, J. Verheij, W. H. Lamers. Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patientsPediatric Blood & Cancer 2019; 66(2): e27475 doi: 10.1002/pbc.27475
28
K. Pandima Devi, B. Sivamaruthi, PV Kiruthiga, S. Karutha Pandian. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habitsHuman & Experimental Toxicology 2010; 29(6): 451 doi: 10.1177/0960327109354938
29
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinomaTranslational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001